MY CLINIC
The cost of diabetes mellitus treatment with stem cells in Czechia typically ranges from $12,000 to $25,000. Prices vary depending on the clinic, the specialist’s experience, the type of stem cells used (autologous or allogeneic), and the number of treatment sessions. In the United States, the average cost is $40,000 (per ASRM). This means diabetes stem cell therapy in Czechia is about 54% less than in the U.S.
Czech clinics usually include pre-treatment consultation, lab diagnostics, stem cell harvesting, cell processing, the infusion procedure, and follow-up visits. In the U.S., costs for cell collection, processing, and post-procedure care are often billed separately. Always confirm exactly what’s included at each clinic.
| Czech Republic | Turkey | Austria | |
| Diabetes mellitus treatment with stem cells | from $12,000 | from $12,000 | from $25,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Diabetes mellitus treatment with stem cells upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Diabetes mellitus treatment with stem cells and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Diabetes mellitus treatment with stem cells journey.
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
Week 1-3 post-operation
Week 4-6 post-operation
Please note that the recovery timeline may vary as each case is individual.
Written by Mariia Mytrofankina
Stem cell treatment for diabetes mellitus involves using regenerative therapy to repair or replace damaged pancreatic cells, aiming to improve insulin production and glucose control.
Stem cell therapy for diabetes mellitus is not an officially approved standard cure in the Czech Republic. The State Institute for Drug Control (SUKL) and the Ministry of Health categorize these treatments as experimental. Current care relies on insulin and oral medications within European Union clinical guidelines.
Bookimed Expert Insight: While clinics like MY CLINIC in Prague maintain high SAK quality standards, they focus on conventional specialties. Data shows that patients seeking stem cell therapy often look toward Turkey or Mexico, where clinical trial access is more frequent. In the Czech Republic, true stem cell applications for diabetes remain tied to academic research at institutions like Charles University.
Patient Consensus: Many state that marketing claims of a permanent cure are often oversold. Patients advise verifying if a procedure is part of a registered trial before committing to any experimental treatment.
Commercial stem cell treatments for diabetes in the Czech Republic are not regulated as standard proven therapies under European Medicines Agency (EMA) standards. While clinics must follow national laws, these specific procedures often operate under hospital exemptions for experimental use rather than formal European Union marketing authorization.
Bookimed Expert Insight: Czech medical centers like MY CLINIC in Prague hold SAK accreditation for inpatient safety. However, this validates hospital management rather than the efficacy of experimental stem cell injections. Patients should prioritize clinics affiliated with major research bodies like Charles University to ensure a higher level of medical scrutiny.
Patient Consensus: Patients emphasize that legitimate clinical trials for diabetes typically do not charge fees. Many advise treating the European clinic label as a marketing term rather than proof of therapy success.
Prague clinics primarily explore autologous mesenchymal stem cells (MSCs) for diabetes treatment. These adult cells come from a patient's own fat tissue or bone marrow. Doctors use them to help regulate immune responses and reduce inflammation in both Type 1 and Type 2 diabetes cases.
Bookimed Expert Insight: Prague clinics often partner with major academic institutions like Charles University. This collaboration bridges the gap between private care and research. It ensures patients get access to methods that focus on protecting existing insulin production. Clinics here emphasize metabolic support over experimental cell replacement.
Patient Consensus: Patients emphasize the need to clarify if a clinic uses embryonic, cord, or adult cells. Many advise verifying if the goal is actual insulin production or general symptom support.
Stem cell treatment packages in the Czech Republic for diabetes bundle medical consultations, laboratory blood panels, and the cellular procedure itself. Most programs in Prague use autologous cells from bone marrow or fat tissue, costing between $12,000 and $25,000.
Bookimed Expert Insight: While Czech clinics like MY CLINIC maintain high SAK quality standards, they often operate as outpatient centers. This means packages usually lack the multi-night hospital stays common in other countries. You should budget separately for Prague hotels since these are rarely bundled in the baseline medical price.
Patient Consensus: Real results often lead to modest insulin dose changes rather than a total cure. Focus on clinics that offer clear monitoring and follow-up rather than those promising one-time guarantees.